Showing results (111-120 of 297) with videos related to

Sort By:
Pageof 30
Anticancer Research|May 25, 2004
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancerWolfgang J Köstler, Günther G Steger, Afschin Soleiman, et al.
International Journal of Cancer|September 15, 2005
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancerGernot Hudelist, Wolfgang J Köstler, Klaus Czerwenka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast CancerChristian F Singer, , Frederik Holst, et al.
BMC Cancer|December 7, 2010
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patientsEva Obermayr, Fatima Sanchez-Cabo, Muy-Kheng M Tea, et al.
Anti-Cancer Drugs|January 19, 2005
Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experienceWolfgang J Köstler, Günther G Steger, Michael Krainer, et al.
Virchows Archiv : an International Journal of Pathology|August 5, 2025
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancerMyriam Stolz, Alex Farr, Kristina A Tendl-Schulz, et al.
Plos One|April 18, 2018
Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriersDaphne Gschwantler-Kaulich, Sigrid Weingartshofer, Christine Rappaport-Fürhauser, et al.
Plos One|March 3, 2017
PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancerDaphne Gschwantler-Kaulich, Yen Y Tan, Eva-Maria Fuchs, et al.
International Orthopaedics|March 27, 2010
Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcomaBernd Kubista, Florian Klinglmueller, Martin Bilban, et al.
Plos One|December 16, 2017
Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriersDaphne Gschwantler-Kaulich, Sigrid Weingartshofer, Christine Rappaport-Fürhauser, et al.
Pageof 30